SCHEMBL9709432

SCHEMBL9709432

[CH]c1cccc2cc(OC)ccc12

nearest known ligand 0.57

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
CYP2A6 P11509 1/20 0.55
ACHE P22303 2/20 0.47
MTNR1A P48039 3/20 0.46
MTNR1B P49286 1/20 0.46
HSD17B1 P14061 1/20 0.44
HSD17B2 P37059 1/20 0.44
HTR2A P28223 1/20 0.44
IDH1 O75874 1/20 0.44
SIRT2 Q8IXJ6 1/20 0.43
SIRT1 Q96EB6 1/20 0.43
SIRT3 Q9NTG7 1/20 0.43
SIRT5 Q9NXA8 1/20 0.43
RAD52 P43351 1/20 0.42
GSTP1 P09211 1/20 0.42
RELA Q04206 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9709434 1.00 CYP1A2 (0.55) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL5510892 0.78 CYP1A2 (0.59) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL443271 0.78 CYP1A2 (0.57) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL29869216 0.78 CYP1A2 (0.57) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL9967888 0.78 CYP1A2 (0.52) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL1806697 0.77 CYP1A2 (0.55) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL7420941 0.77 CYP1A2 (0.55) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL1806698 0.77 CYP1A2 (0.55) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL1402628 0.77 CYP1A2 (0.55) CYP1A2CYP2A6ACHEMTNR1AMTNR1B
SCHEMBL774076 0.77 CYP1A2 (0.55) CYP1A2CYP2A6MTNR1AMTNR1BHSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992020227-A1 SUBSTITUTED ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE ORAL-D (US) 1992-11-26 WO disclosed
US-5047421-A Treating trivalent metal overload conditions in humans ORAL-D (US) 1991-09-10 US disclosed
US-5015664-A Orally effective ion chelators related to deferoxamine ORAL D (US) 1991-05-14 US disclosed
US-4684482-A DEFEROXAMINE DERIVATIVES ORAL-D (L.P.) (US) 1987-08-04 US disclosed
US-4671901-A DIFEROXAMINE DERIVATIVES FOR REDUCTION OF METAL ION TUSSUE OV ERLOAD ORAL-D (US) 1987-06-09 US disclosed
EP-0171414-A1 ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE. ORAL D (US) 1986-02-19 EP disclosed
WO-1985003290-A1 ORALLY EFFECTIVE ION CHELATORS RELATED TO DEFEROXAMINE ORAL-D (US) 1985-08-01 WO disclosed